Skip to main content

Table 4 Medial and lateral meniscus pathology—frequencies of scores

From: Low-dose xenogeneic mesenchymal stem cells target canine osteoarthritis through systemic immunomodulation and homing

Day 42 ± 4 or premature removal

T1 (N = 8)

T2 (N = 8)

T3 (N = 8)

T4 (N = 8)

Global test

T1 vs. T4

T2 vs. T4

T3 vs. T4

Medial meniscus

 n

8

8

8

8

    

 Mean (SD)

0.3 (0.71)

0.0 (0.00)

0.9 (1.81)

2.9 (2.42)

0.005

0.025

0.012

0.092

 Min-max

0–2

0–0

0–5

0–7

    

 Median

0.0

0.0

0.0

2.5

    

 Q1–Q3

0.0–0.0

0.0–0.0

0.0–1.0

1.0–4.5

    

Lateral meniscus

 n

8

8

8

8

    

 Mean (SD)

1.0 (1.20)

0.0 (0.00)

0.6 (1.19)

2.8 (1.16)

< 0.001

0.035

0.003

0.017

 Min-max

0–3

0–0

0–3

1–4

    

 Median

0.5

0.0

0.0

2.5

    

 Q1–Q3

0.0–2.0

0.0–0.0

0.0–1.0

2.0–4.0

   Â